Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3;24(7):e202200760.
doi: 10.1002/cbic.202200760. Epub 2023 Mar 2.

Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors

Marie-Theres Hutchison  1 , Giovanni Bellomo  2 , Alexey Cherepanov  1 , Elke Stirnal  1 , Boris Fürtig  1 , Christian Richter  1 , Verena Linhard  1 , Elina Gurewitsch  1 , Moreno Lelli  3   4 , Nina Morgner  5 , Thomas Schrader  6 , Harald Schwalbe  1
Affiliations

Modulation of Aβ42 Aggregation Kinetics and Pathway by Low-Molecular-Weight Inhibitors

Marie-Theres Hutchison et al. Chembiochem. .

Abstract

The aggregation of amyloid-β 42 (Aβ42) is directly related to the pathogenesis of Alzheimer's disease. Here, we have investigated the early stages of the aggregation process, during which most of the cytotoxic species are formed. Aβ42 aggregation kinetics, characterized by the quantification of Aβ42 monomer consumption, were tracked by real-time solution NMR spectroscopy (RT-NMR) allowing the impact that low-molecular-weight (LMW) inhibitors and modulators exert on the aggregation process to be analysed. Distinct differences in the Aβ42 kinetic profiles were apparent and were further investigated kinetically and structurally by using thioflavin T (ThT) and transmission electron microscopy (TEM), respectively. LMW inhibitors were shown to have a differential impact on early-state aggregation. Insight provided here could direct future therapeutic design based on kinetic profiling of the process of fibril formation.

Keywords: NMR spectroscopy; aggregation; amyloid beta-peptides; inhibitors; kinetics.

PubMed Disclaimer

References

    1. Alzheimer's Association Report, “Alzheimer's Dement. 2020, 16, 391-460.
    1. D. J. Selkoe, J. Hardy, EMBO Mol. Med. 2016, 8, 595-608.
    1. G. G. Glenner, C. W. Wong, Biochem. Biophys. Res. Commun. 1984, 120, 885-890.
    1. J. Davis-Salinas, S. M. Saporito-Irwin, C. W. Cotman, W. E. Van Nostrand, J. Neurochem. 1995, 65, 931-934.
    1. I. Bertini, L. Gonnelli, C. Luchinat, J. Mao, A. Nesi, J. Am. Chem. Soc. 2011, 133, 16013-16022.

Publication types

LinkOut - more resources